Expression of receptor activator of NF-kB ligand (RANKL) on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

被引：0

作者：

Heider, U

Jakob, C

Zavrski, I

Langelotz, C

Fleissner, C

Schulz, CO

Eucker, J

Possinger, K

Hofbauer, LC

Sezer, O

机构：

[1] Universitatsklinikum Charite, Dept Hematol & Oncol, Berlin, Germany

[2] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, D-35032 Marburg, Germany

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3190

引用

页码：808A / 808A

页数：1

共 50 条

[21] A phase Ib study of JMT103, a receptor activator of NF-kB ligand (RANKL) antibody, in patients (pts) with bone metastases from solid tumors.
Ran, Ran
Li, Hongtao
Zhou, Huan
Sun, Tao
Zang, Ai-min
Guo Hongqian
Xie, Hua
Wu, Shikai
Yan, Yong
Yin, Xing
Xiong, Hailin
Li, Hong
Yuan, Jing
Li, Huiping
Li, Jin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[22] Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis
Ho, Teh-Yuan
Santora, Karen
Chen, Joseph C.
Frankshun, Amy-Lynn
Bagnell, Carol A.
BONE, 2011, 48 (06) : 1346 - 1353
[23] Dysregulation of the Receptor Activator of NF-κB Ligand and Osteoprotegerin Production Influence the Apoptosis of Multiple Myeloma Patients’ Bone Marrow Stromal Cells Co-Cultured with Myeloma Cells
Barbara Zdzisińska
Agnieszka Bojarska-Junak
Adam Walter-Croneck
Martyna Kandefer-Szerszeń
Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 153 - 163
[24] Dysregulation of the Receptor Activator of NF-κB Ligand and Osteoprotegerin Production Influence the Apoptosis of Multiple Myeloma Patients' Bone Marrow Stromal Cells Co-Cultured with Myeloma Cells
Zdzisinska, Barbara
Bojarska-Junak, Agnieszka
Walter-Croneck, Adam
Kandefer-Szerszen, Martyna
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (02) : 153 - 163
[25] Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes:: a potential role in multiple myeloma bone disease
Giuliani, N
Colla, S
Sala, R
Moroni, M
Lazzaretti, M
La Monica, S
Bonomini, S
Hojden, M
Sammarelli, G
Barillè, S
Bataille, R
Rizzoli, V
BLOOD, 2002, 100 (13) : 4615 - 4621
[26] Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
E Spanoudakis
M Papoutselis
E Terpos
M A Dimopoulos
C Tsatalas
D Margaritis
A Rahemtulla
I Kotsianidis
A Karadimitris
Blood Cancer Journal, 2016, 6 : e500 - e500
[27] Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
Spanoudakis, E.
Papoutselis, M.
Terpos, E.
Dimopoulos, M. A.
Tsatalas, C.
Margaritis, D.
Rahemtulla, A.
Kotsianidis, I.
Karadimitris, A.
BLOOD CANCER JOURNAL, 2016, 6 : e500 - e500
[28] Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor
Mekhloufi, Abdelilah
Kosta, Andrea
Stabile, Helena
Molfetta, Rosa
Zingoni, Alessandra
Soriani, Alessandra
Cippitelli, Marco
Paolini, Rossella
Gismondi, Angela
Ricciardi, Maria Rosaria
Petrucci, Maria Teresa
Masuelli, Laura
Caracciolo, Giulio
Palchetti, Sara
Santoni, Angela
Fionda, Cinzia
CANCERS, 2020, 12 (02)
[29] Neoplastic plasma cells are demonstrable at bone marrow sites distant to solitary plasmacytoma of bone and predict for progression to multiple myeloma.
Hill, Quentin A.
de Tute, Ruth M.
Child, J. Anthony
Rawstron, Andy C.
Owen, Roger G.
BLOOD, 2006, 108 (11) : 1001A - 1002A
[30] Novel and unusual expression of carbohydrate moieties on bone marrow mesenchymal progenitor cells in multiple myeloma.
Calabro, A
Darr, A
Hascall, VC
Masellis, AM
BLOOD, 2000, 96 (11) : 365A - 365A

← 1 2 3 4 5 →